Buy or sell Aspen Neuroscience stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Aspen Neuroscience Stock

Aspen Neuroscience is a biotechnology company that uses innovative genomic approaches combined with stem cell biology.

About Aspen Neuroscience Stock

Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It develops enabling technologies for patient-specific induced pluripotent stem cell-based therapies.

Funding History

December 2019$6.5M
April 2020$70.0M
May 2022$148M

Management

Co-Founder & Chief Scientific Officer

Jeanne Loring

Board Member, Seed Investor

Drew Spaventa

Chief Scientific Officer

Xiaokui Zhang

Chairman of the Board

Faheem Hasnain

Investor

Afif Khoury

Board Member

Thomas Daniel

Board Member

Doug Fisher

CFO

Kameel Farag

SVP, Research and Development

Andres Bratt-Leal

Board Member

Peter Thompson

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo